Godlewski Grzegorz, Jourdan Tony, Szanda Gergő, Tam Joseph, Cinar Resat, Harvey-White Judith, Liu Jie, Mukhopadhyay Bani, Pacher Pál, Ming Mo Fong, Osei-Hyiaman Douglas, Kunos George
Laboratory of Physiologic Studies , National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health, 5625 Fishers Lane, RM 2S-18, MSC-9413, Bethesda, Maryland 20892-9413, U.S.A.
Laboratory of Cardiovascular Physiology and Tissue Injury, National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health, 5625 Fishers Lane, RM 2N-17, MSC-9413, Bethesda, Maryland 20892-9413, U.S.A.
Sci Rep. 2015 Oct 12;5:14953. doi: 10.1038/srep14953.
We report an unexpected link between aging, thermogenesis and weight gain via the orphan G protein-coupled receptor GPR3. Mice lacking GPR3 and maintained on normal chow had similar body weights during their first 5 months of life, but gained considerably more weight thereafter and displayed reduced total energy expenditure and lower core body temperature. By the age of 5 months GPR3 KO mice already had lower thermogenic gene expression and uncoupling protein 1 protein level and showed impaired glucose uptake into interscapular brown adipose tissue (iBAT) relative to WT littermates. These molecular deviations in iBAT of GPR3 KO mice preceded measurable differences in body weight and core body temperature at ambient conditions, but were coupled to a failure to maintain thermal homeostasis during acute cold challenge. At the same time, the same cold challenge caused a 17-fold increase in Gpr3 expression in iBAT of WT mice. Thus, GPR3 appears to have a key role in the thermogenic response of iBAT and may represent a new therapeutic target in age-related obesity.
我们报告了衰老、产热和体重增加之间通过孤儿G蛋白偶联受体GPR3存在的意外联系。缺乏GPR3且以正常饲料喂养的小鼠在出生后的前5个月体重相似,但此后体重显著增加,总能量消耗减少,核心体温降低。到5个月大时,与野生型同窝小鼠相比,GPR3基因敲除小鼠的产热基因表达和解偶联蛋白1蛋白水平已经较低,肩胛间棕色脂肪组织(iBAT)的葡萄糖摄取受损。GPR3基因敲除小鼠iBAT中的这些分子偏差在环境条件下体重和核心体温出现可测量差异之前就已存在,但与急性冷刺激期间无法维持热稳态有关。与此同时,相同的冷刺激导致野生型小鼠iBAT中Gpr3表达增加17倍。因此,GPR3似乎在iBAT的产热反应中起关键作用,可能代表与年龄相关肥胖的新治疗靶点。